CClinicalTrials.gg
CompletedNCT06238258Updated Mar 25, 2026

Dual Diagnosis Training Trial

An interventional study of SPECTROM Training in Training Group, sponsored by University of New Mexico. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-25.

Sponsored by University of New Mexico · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a clinical trial, with participants undergoing the 16 hour SPECTROM training, and completing 2 assessments before and after training (the Psychotropic Knowledge Questionnaire-Revised and the Management of Aggression and Violence Attitude Scale-Revised-ID).

02

Conditions studied

  • Training Group

Keywords

  • intellectual disability
03

In context

Intellectual Disability

363 studies on the registry are indexed under Intellectual Disability; 103 are open to participants now.

This study's enrollment of 55 is close to the median of 53 across 236 interventional studies indexed under Intellectual Disability.

Browse Intellectual Disability studies →

Lead sponsor

University of New Mexico is the lead sponsor of 306 studies on the registry; 28 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 23 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Inclusion criteria are individuals who work in the 3 ARCA group homes or in the UNM psychiatric center and who are fluent in English and 18 years and older

Exclusion criteria

Exclusion Criteria:

  • All participants must be fluent in English because for this pilot study we do not have funds to translate study materials.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Training Arm

    Behavioral: SPECTROM Training

Interventions

  • BehavioralSPECTROM Training

    Training regarding treatment of behavioral challenges in adults with intellectual disability

06

What researchers measure

Primary outcomes

  1. Knowledge Acquisition Post Training

    Completion of assessments

    Time frame: 6 months

07

Study locations

1 site
  • UNM Health Science Center
    Albuquerque, New Mexico 87106, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06238258
Lead sponsor
University of New Mexico
Responsible party
John Philips (Professor Emeritus, University of New Mexico) — Principal investigator
First posted
Feb 2, 2024
Start date
Jul 1, 2024
Primary completion
Nov 1, 2025
Completion
Dec 1, 2025
Last update
Mar 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion